Marcella Alsan, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Human Rights | 1 | 2023 | 307 | 0.720 |
Why?
|
Information Seeking Behavior | 1 | 2020 | 113 | 0.690 |
Why?
|
Drug Utilization | 2 | 2015 | 1183 | 0.680 |
Why?
|
Penicillins | 1 | 2021 | 380 | 0.650 |
Why?
|
Trust | 2 | 2020 | 505 | 0.640 |
Why?
|
Consumer Health Information | 1 | 2020 | 211 | 0.630 |
Why?
|
Syphilis | 1 | 2019 | 227 | 0.580 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 860 | 0.580 |
Why?
|
Plasmids | 1 | 2020 | 2308 | 0.500 |
Why?
|
Community-Acquired Infections | 1 | 2018 | 465 | 0.490 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5319 | 0.490 |
Why?
|
Poverty | 3 | 2018 | 2660 | 0.470 |
Why?
|
Urinary Tract Infections | 1 | 2020 | 788 | 0.470 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2018 | 564 | 0.470 |
Why?
|
Mortality | 2 | 2021 | 2862 | 0.440 |
Why?
|
Candidiasis | 2 | 2015 | 366 | 0.430 |
Why?
|
Motivation | 2 | 2023 | 1971 | 0.410 |
Why?
|
Drug Resistance, Bacterial | 2 | 2018 | 1030 | 0.400 |
Why?
|
Lymphadenitis | 1 | 2011 | 98 | 0.370 |
Why?
|
Tularemia | 1 | 2010 | 36 | 0.370 |
Why?
|
Attitude to Health | 1 | 2020 | 2052 | 0.370 |
Why?
|
Educational Status | 2 | 2021 | 2540 | 0.370 |
Why?
|
Anti-Infective Agents | 2 | 2015 | 971 | 0.360 |
Why?
|
Bacterial Infections | 1 | 2018 | 1400 | 0.350 |
Why?
|
Seasons | 1 | 2015 | 1493 | 0.350 |
Why?
|
Public Health | 2 | 2021 | 2603 | 0.320 |
Why?
|
Candida albicans | 1 | 2011 | 394 | 0.320 |
Why?
|
Clinical Competence | 1 | 2023 | 4687 | 0.310 |
Why?
|
Developing Countries | 5 | 2022 | 2815 | 0.310 |
Why?
|
Abscess | 1 | 2010 | 607 | 0.280 |
Why?
|
Health Education | 1 | 2013 | 1056 | 0.280 |
Why?
|
Neck | 1 | 2010 | 698 | 0.270 |
Why?
|
Medication Adherence | 1 | 2017 | 2063 | 0.270 |
Why?
|
Health Status Disparities | 1 | 2017 | 1796 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.260 |
Why?
|
India | 3 | 2022 | 2200 | 0.250 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9944 | 0.250 |
Why?
|
Influenza, Human | 1 | 2015 | 1480 | 0.240 |
Why?
|
Internship and Residency | 1 | 2023 | 5787 | 0.230 |
Why?
|
Communicable Diseases | 1 | 2011 | 880 | 0.220 |
Why?
|
Jurisprudence | 1 | 2023 | 110 | 0.220 |
Why?
|
Health Expenditures | 1 | 2015 | 2348 | 0.210 |
Why?
|
Anti-HIV Agents | 2 | 2017 | 4255 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.210 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7172 | 0.210 |
Why?
|
Masks | 2 | 2022 | 197 | 0.200 |
Why?
|
Socioeconomic Factors | 4 | 2020 | 7784 | 0.190 |
Why?
|
HIV Infections | 3 | 2017 | 16715 | 0.190 |
Why?
|
Certification | 1 | 2023 | 423 | 0.180 |
Why?
|
Georgia | 2 | 2017 | 187 | 0.180 |
Why?
|
Income | 2 | 2020 | 1913 | 0.180 |
Why?
|
Population Dynamics | 1 | 2021 | 302 | 0.170 |
Why?
|
Italy | 1 | 2021 | 829 | 0.170 |
Why?
|
Knowledge | 1 | 2020 | 181 | 0.160 |
Why?
|
Typhoid-Paratyphoid Vaccines | 1 | 2018 | 39 | 0.160 |
Why?
|
Klebsiella pneumoniae | 1 | 2020 | 249 | 0.160 |
Why?
|
beta-Lactamases | 1 | 2020 | 304 | 0.160 |
Why?
|
Bacteriuria | 1 | 2018 | 102 | 0.150 |
Why?
|
Health Facilities | 1 | 2023 | 572 | 0.150 |
Why?
|
Humans | 26 | 2024 | 743811 | 0.150 |
Why?
|
Salmonella typhi | 1 | 2018 | 201 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25032 | 0.140 |
Why?
|
Vaccines, Conjugate | 1 | 2018 | 333 | 0.140 |
Why?
|
Quinolones | 1 | 2020 | 368 | 0.140 |
Why?
|
Typhoid Fever | 1 | 2018 | 197 | 0.140 |
Why?
|
Genes, Bacterial | 1 | 2020 | 1078 | 0.140 |
Why?
|
Culture | 1 | 2020 | 632 | 0.140 |
Why?
|
California | 1 | 2020 | 1402 | 0.130 |
Why?
|
Video Recording | 1 | 2020 | 949 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3524 | 0.130 |
Why?
|
Medicine | 1 | 2024 | 945 | 0.130 |
Why?
|
Treatment Refusal | 1 | 2017 | 421 | 0.120 |
Why?
|
Male | 15 | 2024 | 349776 | 0.120 |
Why?
|
Esophageal Diseases | 1 | 2015 | 167 | 0.120 |
Why?
|
Pandemics | 4 | 2022 | 8385 | 0.120 |
Why?
|
Patient Participation | 1 | 2023 | 1457 | 0.120 |
Why?
|
Incidence | 3 | 2020 | 20948 | 0.110 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2015 | 249 | 0.110 |
Why?
|
Adult | 10 | 2024 | 213889 | 0.110 |
Why?
|
Demography | 1 | 2017 | 1653 | 0.100 |
Why?
|
Family Characteristics | 1 | 2017 | 1000 | 0.100 |
Why?
|
Female | 14 | 2024 | 380020 | 0.100 |
Why?
|
Minority Groups | 1 | 2019 | 1222 | 0.100 |
Why?
|
Gender Identity | 1 | 2017 | 686 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2015 | 656 | 0.100 |
Why?
|
Health Promotion | 2 | 2021 | 2205 | 0.100 |
Why?
|
Fluconazole | 1 | 2011 | 146 | 0.100 |
Why?
|
Patients | 1 | 2017 | 899 | 0.100 |
Why?
|
Adolescent | 6 | 2020 | 85729 | 0.090 |
Why?
|
Patient Selection | 1 | 2023 | 4210 | 0.090 |
Why?
|
Communicable Disease Control | 2 | 2022 | 856 | 0.090 |
Why?
|
Birth Rate | 1 | 2011 | 170 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1240 | 0.090 |
Why?
|
United States | 4 | 2023 | 69859 | 0.090 |
Why?
|
Haiti | 1 | 2011 | 553 | 0.090 |
Why?
|
Child Mortality | 1 | 2011 | 198 | 0.080 |
Why?
|
Rwanda | 1 | 2011 | 703 | 0.080 |
Why?
|
Uganda | 1 | 2013 | 1237 | 0.080 |
Why?
|
Ciprofloxacin | 1 | 2010 | 314 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 56392 | 0.080 |
Why?
|
Escherichia coli | 1 | 2020 | 4216 | 0.080 |
Why?
|
Pregnancy | 2 | 2020 | 29140 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 7908 | 0.070 |
Why?
|
Aged | 5 | 2022 | 163178 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2011 | 729 | 0.070 |
Why?
|
Middle Aged | 7 | 2024 | 213241 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 3921 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1125 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3229 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 1872 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3275 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2011 | 847 | 0.070 |
Why?
|
Health Personnel | 1 | 2019 | 3217 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1877 | 0.070 |
Why?
|
Sex Factors | 2 | 2017 | 10394 | 0.060 |
Why?
|
Linear Models | 1 | 2015 | 5952 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8316 | 0.060 |
Why?
|
Child, Preschool | 3 | 2018 | 40964 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3887 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 1411 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15211 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4569 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57744 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16361 | 0.050 |
Why?
|
Medicare | 2 | 2022 | 6565 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 21733 | 0.050 |
Why?
|
Social Marketing | 1 | 2021 | 52 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8035 | 0.050 |
Why?
|
Health Behavior | 2 | 2024 | 2634 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10259 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5136 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 11729 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18355 | 0.040 |
Why?
|
Cultural Competency | 1 | 2021 | 289 | 0.040 |
Why?
|
Cameroon | 1 | 2017 | 71 | 0.040 |
Why?
|
Contrast Media | 1 | 2010 | 5301 | 0.040 |
Why?
|
Child | 3 | 2022 | 77637 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12954 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11708 | 0.030 |
Why?
|
Risk Factors | 2 | 2018 | 72252 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2022 | 77410 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2017 | 63042 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3020 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2560 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3748 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20121 | 0.020 |
Why?
|
Biomedical Research | 1 | 2022 | 3308 | 0.020 |
Why?
|
Viral Load | 1 | 2015 | 3300 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5388 | 0.020 |
Why?
|
Health Care Costs | 1 | 2017 | 3207 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35122 | 0.010 |
Why?
|